Overview
The purpose of this study is to assess UDFF performance (compared to MRI)
Eligibility
Inclusion Criteria:
- All patients who had hepatic ultrasound with available UDFF measurements and hepatic MRI (with steatosis quantification sequences) between 01/01/2022 and 31/09/2023 may be included.
Exclusion Criteria:
- chronic liver disease with a different etiology other than NAFL/NASH or mixed (hepatitis B or C, hemochromatosis, autoimmune hepatitis, Wilson's disease, cholestasic disease, alpha 1 antitrypsin deficiency),
- decompensated cirrhosis (ascites, jaundice, encephalopathy, rupture of esophageal varices),
- hepatocellular carcinoma.
- opposition to the use of its data